Plasma levels of alpha-1-antichymotrypsin are elevated in patients with chronic heart failure, but are of limited prognostic value

BACKGROUND: There is increasing interest in utilising novel markers of cardiovascular disease risk in patients with chronic heart failure (HF). Recently, it was shown that alpha-1-antichymotrypsin (ACT), an acute-phase protein and major inhibitor of cathpesin G, plays a role in the pathophysiology o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lok, S. I., Lok, D. J., van der Weide, P., Winkens, B., Bruggink-André de la Porte, P. W., Doevendans, P. A., de Weger, R. A., van der Meer, P., de Jonge, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2014
Materias:
Original Article E-learning
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160451/
https://www.ncbi.nlm.nih.gov/pubmed/25172361
http://dx.doi.org/10.1007/s12471-014-0584-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160451/
https://www.ncbi.nlm.nih.gov/pubmed/25172361
http://dx.doi.org/10.1007/s12471-014-0584-2

Ejemplares similares